Has Marye Gleva, MD received payments from drug or device companies?

Yes. Drug and device makers reported $28,058 in general payments to Marye Gleva, MD across 104 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Marye Gleva, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Marye Gleva, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Marye Gleva, MD

Clinical Cardiac Electrophysiology · Saint Louis, MONPI 1194741322

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (40.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Abbott at 30.7% of the total. Reporting peaked in 2023 at $7,933 and has fallen 94.6% since, to $425 in 2025.

$28,058in general payments, 2019–2025

Across 104 payments — averaging $269.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$9K
Biotronik Inc.$6K
Medtronic$5K
Boston Scientific$4K
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$3K
Biosense Webster, Inc.$245
plus $122 from 1 others

$303,430in research payments, 2019–2025

Across 117 payments — averaging $2593.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$173K
Janssen Research & Development, LLC$62K
Boston Scientific$59K
Biotronik Inc.$10K

What the payments were for

Consulting fees$6,12522%
Speaking & faculty fees$11,27540%
Travel & lodging$6,01221%
Food & beverage$4,64617%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	60	$8,621
Biotronik Inc.	9	$6,203
Medtronic(2 entities)	16	$5,333
Boston Scientific	9	$4,211
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	6	$3,324
Biosense Webster, Inc.	2	$245
Cardiva Medical, Inc.	2	$122

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ENSITE PRECISION$6,026
LifeVest$3,000
GENERAL - THERAPIES$2,500
Solia$2,400
Protego$2,375
S-ICD System Magnet$875
LITHOVUE EMPOWER$735
AVEIR$319
TACTICATH ABLATION CATHETER, SENSOR ENABLED$313
Xience V coronary stent system$146
Carto 3$128
Carto Smarttouch$117
Carto 3 System$117

How this compares

$28,058 in reported general payments places this provider in the 65th percentile of 74 clinical cardiac electrophysiology providers in Missouri.

See all clinical cardiac electrophysiology providers in Missouri →

Medicare billing

Part B allowed, 2024

$168,915

Medicare patients

571

Services billed

2,991

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	423	$363,976
XareltoRivaroxaban	71	$57,953
Dofetilide	130	$30,815
EntrestoSacubitril/Valsartan	46	$29,518
CorlanorIvabradine Hcl	21	$12,874
FarxigaDapagliflozin Propanediol	11	$8,753
Amiodarone Hcl	201	$5,614
Metoprolol Succinate	218	$2,630
Mexiletine Hcl	35	$2,358
SotalolSotalol Hcl	172	$1,931
Nebivolol Hcl	20	$1,588
Metoprolol Tartrate	99	$616
Digoxin	12	$426
Warfarin Sodium	36	$288
Spironolactone	30	$198

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Saint Louis

Phillip CuculichSaint Louis$473K
Daniel CooperSaint Louis$168K
Krasimira MikhovaSaint Louis$52K
Gregory BotteronSaint Louis$52K
Ali MehdiradSaint Louis$47K
Milan KahandaSaint Louis$45K
Saulius KalvaitisSaint Louis$43K
Gabriel SotoSaint Louis$39K
Justin PieperSaint Louis$39K
Christopher BauerSaint Louis$38K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →